Median: record order book boosts share price

Median Technologies stood out on the stock market Friday morning after reporting a ‘record’ order book, thanks in particular to the dynamism of its business in China.

The French company, which specializes in medical imaging, reports that its order book reached 71.7 million euros at the end of June, marking an all-time high.

Median – which uses AI tools for the diagnosis and treatment of cancers – explains that its order intake has increased ‘significantly’ in China, where the company says it expects sales to rise in the coming quarters.

But the company points out that initial projects in Japan and South Korea have also significantly improved its positioning in the highly dynamic East Asian clinical trials market.

“We expect these advances to be major catalysts for strong commercial growth in the coming quarters,” promises its CEO and founder, Fredrik Brag.

First-half sales came to €10.9 million, compared with €11.4 million in the same period of 2023.

Final results from the pivotal study on its eyonis LCS AI software suite are expected in August, but the primary and secondary endpoints had already been met.

At June 30, 2024, Media’s cash position stood at 16 million euros, compared with 20.9 million euros at March 31, an amount sufficient to finance its operations until the second quarter of 2025.

The share price jumped 42% following these announcements, bringing its year-to-date decline to 57%.

Copyright (c) 2024 CercleFinance.com. All rights reserved.